Drugs / niflumic acid
niflumic acid
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05761015 | Dec 2023 → Apr 2028 expected | chronic pain syndrome, osteoarthritis, hip, osteoarthritis, knee | University Hospital, Clermont-Ferrand | Recruiting | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | niflumic acid | “no risk: niflumic acid, 250 mg per intake” NCT05761015 ↗ |
| Known as | Acide niflumique | ChEMBL registry synonym — accepted as the source's own label CHEMBL63323 ↗ |
| Known as | Acido niflumico | ChEMBL registry synonym — accepted as the source's own label CHEMBL63323 ↗ |
| Known as | Niflugel | ChEMBL registry synonym — accepted as the source's own label CHEMBL63323 ↗ |
| Known as | NSC-758196 | ChEMBL registry synonym — accepted as the source's own label CHEMBL63323 ↗ |
| Known as | UP 83 | ChEMBL registry synonym — accepted as the source's own label CHEMBL63323 ↗ |
| Modality | Small molecule | — CHEMBL63323 ↗ |